BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang L, Jiang Q, He MY, Shen P. HER2 changes to positive after neoadjuvant chemotherapy in breast cancer: A case report and literature review . World J Clin Cases 2022; 10(1): 260-267 [PMID: 35071526 DOI: 10.12998/wjcc.v10.i1.260]
URL: https://www.wjgnet.com/2307-8960/full/v10/i1/260.htm
Number Citing Articles
1
Pujita Munnangi, Polly Ann Niravath, Jenny C Chang, Kai Sun. HER2-positive breast cancer in patients with BRCA1/2 pathogenic variants: Case series and literature reviewCurrent Problems in Cancer: Case Reports 2024; : 100335 doi: 10.1016/j.cpccr.2024.100335
2
Imane Eliahiai, Mohammed Eljiar, Sanae Chaib, Jinane KHarmoum, Mariame Chraïbi. Récepteur du facteur de croissance épidermique HER2, tests utilisés pour rechercher son amplification dans le cancer du sein : principes et limitesBulletin du Cancer 2023; 110(12): 1301 doi: 10.1016/j.bulcan.2023.08.012